Cargando…

Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway

Telmisartan, a type of angiotensin II (Ang II) receptor inhibitor, is a common agent used to treat hypertension in the clinic. Hypertension increases cardiac afterload and promotes cardiac hypertrophy. However, the ventricular Ang II receptor may be activated in the absence of hypertension. Therefor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiurong, Lan, Yuhuai, Wang, Yan, Nie, Minghao, Lu, Yanhong, Zhao, Eryang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428554/ https://www.ncbi.nlm.nih.gov/pubmed/28447738 http://dx.doi.org/10.3892/mmr.2017.6318

Ejemplares similares

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
por: Zhang, Xin, et al.
Publicado: (2020)

Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy
por: Lunde, Ida G., et al.
Publicado: (2022)

A NFAT decoy approach to inhibit cardiac hypertrophy
por: Heineke, Joerg
Publicado: (2021)

How does NFAT3 regulate the occurrence of cardiac hypertrophy?
por: Hui, Wang, et al.
Publicado: (2023)

Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
por: Bernt, Alexander, et al.
Publicado: (2016)

Gene Expression of ANP, BNP and ET-1 in the Heart of Rats during Pulmonary Embolism
por: Gutte, Henrik, et al.
Publicado: (2010)

Effects of enalaprilat sodium on plasma NTproANP and NTproBNP levels in healthy volunteers
por: Heringlake, M, et al.
Publicado: (2006)

Neuronal NO synthase mediates plenylephrine induced cardiomyocyte hypertrophy through facilitation of NFAT-dependent transcriptional activity
por: Loyer, Xavier, et al.
Publicado: (2019)

ANP and BNP Responses to Dehydration in the One-Humped Camel and Effects of Blocking the Renin-Angiotensin System
por: Adem, Abdu, et al.
Publicado: (2013)

Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway
por: Yoon, Jung Joo, et al.
Publicado: (2020)

Effects of liraglutide on ANP secretion and cardiac dynamics
por: Luo, Shenghe, et al.
Publicado: (2023)

ANP and BNP plasma levels in patients with rheumatic mitral stenosis after percutaneous balloon mitral valvuloplasty
por: Mazurkiewicz, Łukasz, et al.
Publicado: (2017)

GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy
por: Duran, Javier, et al.
Publicado: (2016)

Gestational diabetes triggers postpartum cardiac hypertrophy via activation of calcineurin/NFAT signaling
por: Verma, Nirmal, et al.
Publicado: (2021)

Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling
por: Chen, Yuezhang, et al.
Publicado: (2017)

The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease
por: Heringlake, M, et al.
Publicado: (2009)

Comparative accuracy of NT‐proBNP and MR‐proANP for the diagnosis of acute heart failure in dyspnoeic patients
por: Darche, Fabrice F., et al.
Publicado: (2017)

AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure
por: Remes, Anca, et al.
Publicado: (2021)

Telmisartan regresses left ventricular hypertrophy in caveolin-1 deficient mice
por: Kreiger, Marta H, et al.
Publicado: (2010)

Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy
por: Chang, Tzu-Hao, et al.
Publicado: (2016)

Myocardial Hypertrophy and Fibrosis Are Associated with Cardiomyocyte Beta-Catenin and TRPC6/Calcineurin/NFAT Signaling in Spontaneously Hypertensive Rats with 5/6 Nephrectomy
por: Bogdanova, Evdokia, et al.
Publicado: (2021)

The effects of variations in thoracic blood volume and intravenous sodium loading on plasma levels of NTproANP and NTproBNP in healthy volunteers
por: Heringlake, M, et al.
Publicado: (2004)

Luteolin suppresses lipopolysaccharide-induced cardiomyocyte hypertrophy and autophagy in vitro
por: Li, Xing, et al.
Publicado: (2019)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

Sanggenon C protects against pressure overload-induced cardiac hypertrophy via the calcineurin/NFAT2 pathway
por: Xiao, Lili, et al.
Publicado: (2017)

Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy
por: Luo, Yuxuan, et al.
Publicado: (2021)

Pioglitazone Induces Cardiomyocyte Apoptosis and Inhibits Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway
por: Zhong, Wenliang, et al.
Publicado: (2018)

Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes
por: Ovchinnikova, Ekaterina, et al.
Publicado: (2018)

Effect of tanshinone IIA on cardiomyocyte hypertrophy and apoptosis in spontaneously hypertensive rats
por: JIANG, F.L., et al.
Publicado: (2013)

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022)

Telmisartan Induces Osteosarcoma Cells Growth Inhibition and Apoptosis Via Suppressing mTOR Pathway
por: Wang, Chao, et al.
Publicado: (2018)

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2019)

Mechanisms for the secretion of ANP.
por: Cho, K. W., et al.
Publicado: (1997)

Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease
por: Khaki, Zohreh, et al.
Publicado: (2022)

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice
por: Alharbi, Hajed O., et al.
Publicado: (2022)

Nelumbo nucifera Receptaculum Extract Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy
por: Cho, Soyoung, et al.
Publicado: (2019)

Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011)

Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure
por: Nomura, Seitaro, et al.
Publicado: (2018)

ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
por: Xiang, Mei, et al.
Publicado: (2018)

Hypertrophy-Reduced Autophagy Causes Cardiac Dysfunction by Directly Impacting Cardiomyocyte Contractility
por: Ott, Christiane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_63a5bgm0qv988dq4hp8f38l2av